# Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol

> **NCT01268878** · — · COMPLETED · sponsor: **Groupe Oncologie Radiotherapie Tete et Cou** · enrollment: 130 (actual)

## Conditions studied

- Squamous Cell Head and Neck Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01268878
- **Lead sponsor:** Groupe Oncologie Radiotherapie Tete et Cou
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2014-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01268878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01268878, "Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01268878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*